HCV-ACCELERATE Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The overarching goal of this study is to develop a peer-based care coordination intervention for individuals with Hepatitis C Virus (HCV) who were recently released from correctional settings to promote linkage to and retention in HCV care. The investigators will assess the existing barriers and facilitators of HCV treatment initiation, HCV treatment completion, and sustained virologic response among individuals recently released from a U.S. jail or prisons in a randomized control trial. This study will assess the feasibility and process measures of a peer-enhanced HCV care coordination intervention among recently incarcerated individuals.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• currently incarcerated or recently released from a U.S. jail or prison (6 months)

• Chronic HCV with documented detectable viral load

• 18 years old

• Fluent in English or Spanish

• Resident of the Upstate area of South Carolina

Locations
United States
South Carolina
Prisma Health-Upstate
RECRUITING
Greenville
Contact Information
Primary
Matthew Akiyama, MD
makiyama@montefiore.org
718-920-7175
Backup
Lindsey Riback, MPH
lindsey.riback@einsteinmed.org
201-372-4089
Time Frame
Start Date: 2021-12-17
Estimated Completion Date: 2026-06
Participants
Target number of participants: 80
Treatments
Experimental: Peer-enhanced intervention
Those randomized to the peer-enhanced intervention group will be contacted by a peer mentor within 72 hours of enrollment to discuss the early release period, readiness for HCV treatment, and identify ancillary needs. Individuals randomized to this arm will be provided a study cell phone.
Placebo_comparator: Standard of care
If randomized to the standard of care intervention, the participant will only receive passive referral to HCV-care.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute on Drug Abuse (NIDA), Prisma Health-Upstate
Leads: Montefiore Medical Center

This content was sourced from clinicaltrials.gov